Unable to load price data. Sorry.

¯\_(ツ)_/¯

Questcor Pharmaceuticals (NASDAQ:QCOR.DL)

CAPS Rating: No stars

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:QCOR.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

EpikurFool (24.22)
Submitted March 09, 2013

yes, this company had some problems in the past (Aetna announced that it would restrict coverage of the leading product Acthar Gel). However the figures still encourage to take an outperformance view: Forward PE of 6, PEG 0.35. Very high ROE, Gross… More

goldminingXpert (28.50)
Submitted September 19, 2012

Still waiting patiently for this zero to get to zero. Wasn't expecting it to take half a decade...

NASDAQ:QCOR.DL VS S&P 500 (SPY)

NASDAQ:QCOR.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about QCOR.DL.

No one has written a Pitch for QCOR.DL stock yet. Tell us why you think QCOR.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in QCOR.DL.

No players have picked QCOR.DL yet. Tell us why you think QCOR.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for QCOR.DL.